lobbying_filings_raw: 1ec68fca-e33b-45b1-bae0-9acdc2f2795b
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1ec68fca-e33b-45b1-bae0-9acdc2f2795b | Q2 | 400701094 | GOLDBUG STRATEGIES LLC | 194361 | GENOMIC HEALTH INC. | 2011 | second_quarter | 2011-07-05T17:12:29.537000-04:00 | 110000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/1ec68fca-e33b-45b1-bae0-9acdc2f2795b/", "filing_uuid": "1ec68fca-e33b-45b1-bae0-9acdc2f2795b", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2011, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/1ec68fca-e33b-45b1-bae0-9acdc2f2795b/print/", "filing_document_content_type": "text/html", "income": "110000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Sheila D. Walcoff, Esq. Founding Principal", "dt_posted": "2011-07-05T17:12:29.537000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "9713 Key West Avenue Suite 250", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Rockville", "registrant_state": "MD", "registrant_zip": "20850", "registrant": {"id": 400701094, "url": "https://lda.senate.gov/api/v1/registrants/400701094/", "house_registrant_id": null, "name": "GOLDBUG STRATEGIES LLC", "description": "Personal genomic services firm", "address_1": "510 Diamondback Drive #570", "address_2": null, "address_3": null, "address_4": null, "city": "Rockville", "state": "MD", "state_display": "Maryland", "zip": "20878", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ULYANA KANITSKA", "contact_telephone": "+1 301-355-2661", "dt_updated": "2025-06-07T12:43:12.498936-04:00"}, "client": {"id": 194361, "url": "https://lda.senate.gov/api/v1/clients/194361/", "client_id": 12, "name": "GENOMIC HEALTH INC.", "general_description": "clinical laboratory", "client_government_entity": false, "client_self_select": false, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2011-01-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "FDA regulation of laboratory developed tests.\nMedicare reimbursement for laboratory developed tests.\nTricare payment of laboratory developed tests.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 53398, "prefix": null, "prefix_display": null, "first_name": "SHEILA", "nickname": null, "middle_name": "D", "last_name": "WALCOFF", "suffix": null, "suffix_display": null}, "covered_position": "Committee, US House Of Representatives", "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "FDA regulation of laboratory developed tests.\nMedicare reimbursement for laboratory developed tests.\nTricare payment of laboratory developed tests.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 53398, "prefix": null, "prefix_display": null, "first_name": "SHEILA", "nickname": null, "middle_name": "D", "last_name": "WALCOFF", "suffix": null, "suffix_display": null}, "covered_position": "Committee, US House Of Representatives", "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "FDA regulation of laboratory developed tests.\nMedicare reimbursement for laboratory developed tests.\nTricare payment of laboratory developed tests.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 53398, "prefix": null, "prefix_display": null, "first_name": "SHEILA", "nickname": null, "middle_name": "D", "last_name": "WALCOFF", "suffix": null, "suffix_display": null}, "covered_position": "Committee, US House Of Representatives", "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |